Cargando…

Comparing Prostate Imaging-Reporting and Data System Version 2 (PI-RADSv2) Category 1 and 2 Groups: Clinical Implication of Negative Multiparametric Magnetic Resonance Imaging

OBJECTIVES: To evaluate the clinicopathological differences between Prostate Imaging-Reporting and Data System (PI-RADS) version 2 (v2) category 1 and 2 groups. Materials and Methods. We retrospectively reviewed our two institutional clinical databases: (1) transrectal ultrasound (TRUS)/magnetic res...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Jung Kwon, Lee, Hak Jong, Hwang, Sung Il, Choe, Gheeyoung, Hong, Sung Kyu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7154969/ https://www.ncbi.nlm.nih.gov/pubmed/32337234 http://dx.doi.org/10.1155/2020/2819701

Ejemplares similares

Multiparametric Magnetic Resonance Imaging-based Prostate Specific Antigen Density and PI-RADSv2 score help identify Apical Prostate Cancer
por: Huang, Cong, et al.
Publicado: (2023)

Biparametric versus multiparametric magnetic resonance imaging of the prostate: detection of clinically significant cancer in a perfect match group
por: Cho, Jungheum, et al.
Publicado: (2020)

Multiparametric MRI reporting using Prostate Imaging Reporting and Data System version 2.0 (PI-RADSv2) retains clinical efficacy in a predominantly post-biopsy patient population
por: Aslim, Edwin Jonathan, et al.
Publicado: (2019)

Comparison of different thresholds of PSA density for risk stratification of PI-RADSv2.1 categories on prostate MRI
por: Girometti, Rossano, et al.
Publicado: (2022)

Prognostic value of seminal vesicle invasion on preoperative multi-parametric magnetic resonance imaging in pathological stage T3b prostate cancer
por: Kim, Jung Kwon, et al.
Publicado: (2020)

The effect of 5 alpha-reductase inhibitor therapy on prostate cancer detection in the era of multi-parametric magnetic resonance imaging
por: Kim, Jung Kwon, et al.
Publicado: (2019)

Cancer detection rates of the PI-RADSv2.1 assessment categories: systematic review and meta-analysis on lesion level and patient level
por: Oerther, Benedict, et al.
Publicado: (2021)

Value of T1/T2-weighted magnetic resonance imaging registration to reduce the postbiopsy hemorrhage effect for prostate cancer localization
por: You, Ja Yeon, et al.
Publicado: (2015)

Morphologic perfusion patterns and PI-RADSv2.1 in transition zone prostate cancer
por: Garmer, M., et al.
Publicado: (2023)

An independent practice validation of the Prostate Imaging Reporting and Data System version 2 scoring system and the introduction of PDP (prostate-specific antigen density × PI-RADSv2) score to assist with further risk assessment
por: Patel, Parth U., et al.
Publicado: (2022)

Prostate Cancer Detection with Multiparametric Magnetic Resonance Imaging: Prostate Imaging Reporting and Data System Version 1 versus Version 2
por: Feng, Zhao-Yan, et al.
Publicado: (2016)

Utility of multiple core biopsies during transperineal template-guided mapping biopsy for patients with large prostates and PI-RADS 1–2 on multiparametric magnetic resonance imaging
por: Lee, Chung Un, et al.
Publicado: (2022)

Diagnostic accuracy of F-18-Fluorocholine PET/CT and multiparametric MRI for prostate cancer
por: Kim, Jung Kwon, et al.
Publicado: (2022)

The role of different PI-RADS versions in prostate multiparametric magnetic resonance tomography assessment
por: Aliukonis, Paulius, et al.
Publicado: (2017)

Complementing the active surveillance criteria with multiparametric magnetic resonance imaging
por: Kim, Tae Un, et al.
Publicado: (2020)

Multiparametric magnetic resonance imaging of prostate cancer
por: Hedgire, Sandeep S, et al.
Publicado: (2012)

Multiparametric magnetic resonance imaging of prostate cancer
por: Sivrioglu, Ali Kemal, et al.
Publicado: (2013)

Focal lesion at the midline of the prostate on transrectal ultrasonography: take it or leave it?
por: Kim, Junwoo, et al.
Publicado: (2017)

Developing Strategy to Predict the Results of Prostate Multiparametric Magnetic Resonance Imaging and Reduce Unnecessary Multiparametric Magnetic Resonance Imaging Scan
por: Liu, Junxiao, et al.
Publicado: (2021)

3.0-T multiparametric magnetic resonance imaging modifies the template of endoscopic, conventional radical prostatectomy in all cancer risk categories 
por: Kozikowski, Mieszko, et al.
Publicado: (2018)

Prediction of unilateral prostate cancer by the combination of transrectal ultrasonography-guided prostate biopsy and multi-parametric magnetic resonance imaging: A real-life experience
por: Kim, Jung Jun, et al.
Publicado: (2018)

Diagnostic yield of multiparametric MRI for local recurrence at biochemical recurrence after radical prostatectomy
por: Kim, Minsu, et al.
Publicado: (2022)

Standardization of Multiparametric Prostate MR Imaging Using PI-RADS
por: Bomers, Joyce G. R., et al.
Publicado: (2014)

Multiparametric Magnetic Resonance Imaging Characteristics of Prostate Tuberculosis
por: Cheng, Yue, et al.
Publicado: (2015)

Multiparametric Magnetic Resonance Imaging of Recurrent Prostate Cancer
por: Oppenheimer, Daniel Corey, et al.
Publicado: (2016)

Multiparametric magnetic resonance imaging of the prostate: current concepts
por: Bittencourt, Leonardo Kayat, et al.
Publicado: (2014)

Repeatability and reproducibility of multiparametric magnetic resonance imaging of the liver
por: Bachtiar, Velicia, et al.
Publicado: (2019)

The current role of prostate multiparametric magnetic resonance imaging
por: Rouviere, Olivier, et al.
Publicado: (2019)

Multiparametric Mapping Magnetic Resonance Imaging of Pancreatic Disease
por: Wang, Lixia, et al.
Publicado: (2020)

The multiparametric prostate resonance imaging with the prostate imaging-reporting and data system (PI-RADS): the state of art of prostate cancer diagnosis
Publicado: (2019)

Negative multiparametric magnetic resonance imaging for prostate cancer: further outcome and consequences
por: Haack, Maximilian, et al.
Publicado: (2022)

Corrigendum: Correction of the Affiliation. Complementing the active surveillance criteria with multiparametric magnetic resonance imaging
por: Kim, Tae Un, et al.
Publicado: (2023)

Imaging effective oxygen diffusivity in the human brain with multiparametric magnetic resonance imaging
por: Kufer, Jan, et al.
Publicado: (2021)

Optimum threshold of the 4Kscore for biopsy in men with negative or indeterminate multiparametric magnetic resonance imaging
por: de Almeida S, Ricardo, et al.
Publicado: (2023)

Comparison of Accuracies between Real-Time Nonrigid and Rigid Registration in the MRI–US Fusion Biopsy of the Prostate
por: Hwang, Sung Il, et al.
Publicado: (2021)

Multiparametric magnetic resonance imaging of prostate: the evolution of a technique
por: Muglia, Valdair Francisco
Publicado: (2014)

Multiparametric magnetic resonance imaging findings of prostatic pure leiomyomas
por: Mussi, Thais Caldara, et al.
Publicado: (2016)

Color-coded visualization of magnetic resonance imaging multiparametric maps
por: Kather, Jakob Nikolas, et al.
Publicado: (2017)

Multiparametric Magnetic Resonance Imaging for Active Surveillance of Prostate Cancer
por: An, Julie Y., et al.
Publicado: (2017)

Multiparametric magnetic resonance imaging of the prostate—a basic tutorial
por: Cabarrus, Miguel C., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_pb0n03naobraeksrbvfr64imls